Table 2 Univariate analysis of factors affecting biochemical free survival
Factor | HR (95% CI) | p-value |
|---|---|---|
GS | 1.299 (1.009–1.672) | 0.042 |
< 8 | 1 (reference) | – |
8–10 | 2.007 (1.129–3.569) | 0.018 |
bPSA (ng/ml) | 1.009 (1.001–1.017) | 0.024 |
≤ 20 ng/ml | 1 (reference) | – |
> 20 ng/ml | 1.767 (0.970–3.218) | 0.063 |
T-stage | 2.226 (1.410–3.515) | 0.001 |
T1-T2 | 1 (reference) | – |
T3-T4 | 3.079 (1.691–5.608) | <0.001 |
nPSA (ng/ml) | 2.667 (1.79–3.973) | <0.001 |
< 0.06 | 1 (reference) | – |
≥ 0.06 | 3.887 (1.988–7.599) | <0.001 |
RT dose (Gy) | 0.837 (0.703–0.996) | 0.045 |
PSA pre-RT (ng/ml) | 1.056 (1.0–1.114) | 0.048 |
ADT duration (months) | 0.996 (0.970–1.023) | 0.784 |
Age (years) | 0.968 (0.926–1.012) | 0.148 |
Time to Nadir (months) | 0.999 (0.969–1.031) | 0.965 |